Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 6/20 | 0.35 |
| ▸ | SMO | Q99835 | 3/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21396670 | 0.90 | PTGER4 (0.40) | PTGER4KDM4EALDH1A1L3MBTL1EGLN1 | |
| SCHEMBL19755305 | 0.82 | KDM4E (0.43) | PTGER4KDM4EL3MBTL1CYP19A1CYP11B1 | |
| SCHEMBL28367419 | 0.82 | KDM4E (0.42) | PTGER4KDM4EALDH1A1L3MBTL1CYP19A1 | |
| SCHEMBL19051993 | 0.81 | CA1 (0.41) | PTGER4KDM4EALDH1A1L3MBTL1ATM | |
| SCHEMBL22378507 | 0.81 | KDM4E (0.42) | PTGER4KDM4EL3MBTL1CYP19A1CYP11B1 | |
| SCHEMBL21397055 | 0.81 | ALDH1A1 (0.39) | PTGER4KDM4EALDH1A1L3MBTL1EGLN1 | |
| SCHEMBL21397122 | 0.80 | PTGER4 (0.36) | PTGER4KDM4EALDH1A1L3MBTL1CYP11B2 | |
| SCHEMBL19755261 | 0.80 | STS (0.36) | PTGER4KDM4EL3MBTL1CYP11B1CYP11B2 | |
| SCHEMBL19755312 | 0.80 | STS (0.36) | PTGER4KDM4EL3MBTL1CYP11B1CYP11B2 | |
| SCHEMBL24219897 | 0.80 | PTGER4 (0.42) | PTGER4KDM4EALDH1A1L3MBTL1SMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543230-B1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2021-05-05 | — | — | EP | disclosed |
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC25A21, SLCO4C1, SLC18A1 | PTGER4 2404/4885KDM4E 955/4885ALDH1A1 825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.